Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Genentech describes mTOR inhibitor chosen as development candidate

Sep. 4, 2012

New series of GPR119 agonists optimized by Bristol-Myers Squibb

Sep. 4, 2012

BMS discovers novel P2Y1 receptor antagonists with antithrombotic activity

Sep. 4, 2012

Silodosin evaluated for premature ejaculation

Sep. 4, 2012

Novel calcium channel blocker induces analgesia in cancer pain model

Sep. 4, 2012

Adenosine-based therapy shows promise for the treatment of priapism

Sep. 4, 2012

Gilead presents data on GS-9669 for HCV infection

Sep. 3, 2012

TB Alliance advances development of antitubercular nitroimidazoles

Sep. 3, 2012

Bristol-Myers Squibb profiles novel MCH1 receptor antagonist

Sep. 3, 2012

Mechanism of action of epelsiban besilate further elucidated

Sep. 3, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.